+1 470 300 2858
joseph_l@neurodegenerativesummit.org
Dates: March 18-19, 2026(GMT-UK Time)
Menu
About Our Webinar
The Global Insights on Neurodegenerative Diseases (GIND-2026) returns for its 2nd Edition following the success of our inaugural event. GIND-2026 will be held virtually on March 18–19, 2026 (GMT-UK Time), and will bring together neurologists, researchers, clinicians, technologists, caregivers, and students worldwide for two days of high-impact scientific exchange.
Neurodegenerative disorders — including Alzheimer’s disease, Parkinson’s disease, ALS, Huntington’s disease, and Multiple Sclerosis — present growing clinical and societal challenges as populations age. Building on the momentum from our first edition, this year’s program focuses on translating research into practice: early detection, novel therapeutics, biomarkers, rehabilitation, and digital innovations that improve patient outcomes and quality of life.
GIND-2026 is designed for clinicians, researchers, allied health professionals, and caregivers who want practical, evidence-based insights and global perspectives. Through keynote lectures, focused sessions, and interactive Q&A panels, attendees will gain actionable knowledge to apply in clinical care, research programs, and policy development.
What You Will Learn:
- Key Neurodegenerative Conditions: Clinical features and pathophysiology of Alzheimer’s, Parkinson’s, ALS, Huntington’s, and related disorders.
- Current Clinical Management: Evidence-based pharmacologic and non-pharmacologic approaches, and limitations in long-term care.
- Innovative Therapies: Emerging treatments including gene therapy, stem cells, immunotherapies, and neuroprotective strategies.
- Diagnostics & Biomarkers: Advances in early detection, imaging, fluid biomarkers, and their role in personalized care.
- Digital & Rehabilitation Tools: Cognitive rehab, assistive technologies, tele-neurology, and AI-driven diagnostics.
- Global Collaboration: Addressing research barriers, care disparities, and opportunities for multi-center studies and policy impact.
Scientific Sessions
- Neurodegenerative Diseases Research and Therapy
- Parkinson's Disease
- Alzheimer's Disease
- Huntington's Disease
- ALS (Amyotrophic Lateral Sclerosis)
- Multiple Sclerosis (MS)
- Dementia diagnosis, treatment
- Current Pharmacological Therapies
- Gene Therapy & Genetic Approaches
- Stem Cell Therapy & Regenerative Medicine
- Immunotherapy in Neurodegeneration
- Early Diagnosis & Predictive Biomarkers
- Personalized Medicine in Neurodegenerative Diseases
- Advances in Neuroimaging Techniques
- The Role of Inflammation in Neurodegeneration
- Neuroprotective Strategies
- Advances in Clinical Trials
- AI in Neurodegenerative Research
- Genetic Counseling & Testing
- Diet & Nutrition in Neurodegeneration
- Gut Microbiota and Neurodegeneration
- Mental Health & Social Support for Caregivers
- Ethical & Legal Challenges in Research
- Palliative & End-of-Life Care
- Cross-Disciplinary Approaches
- Antioxidants & Metabolic Therapies
- Neurostimulation & Brain-Computer Interfaces
- Sleep & Circadian Rhythms in Neurodegeneration
- Mild Cognitive Impairment
- Amyloid, Tauopathies and TDP-43 Proteinopathies
- Prion Diseases
- Cognitive Aging and Brain Health
- Neuroimaging and Early Diagnosis
- Frontotemporal Dementia, Vascular Dementia & Lewy Body Dementia
- Brain Disorders & Therapy
Deadlines for Neurodegenerative Diseases-2026
The First Round of Abstract Submission ends on
07 January 2026
Early Bird Registration
08 January 2026
Standard Registration
27 January 2026
Speakers
E-POSTER
YOUNG RESEARCHER
SPEAKER
DELEGATE
🚀 Hurry up! Only 48 seats remaining
Don’t miss this opportunity!
Testimonials
A wonderfully organized and enriching virtual event with diverse international presentations — a truly valuable experience.
Thank you very much for having me; it was a pleasure to take part in the webinar.
Thank you again for the invitation. It was an amazing event indeed.
